Geneos Wealth Management’s Helmerich & Payne HP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-500
Closed -$11K 2502
2025
Q3
$11K Sell
500
-843
-63% -$15.5K ﹤0.01% 1931
2025
Q2
$20.4K Buy
1,343
+1,300
+3,023% +$23.8K ﹤0.01% 2023
2025
Q1
$1.12K Sell
43
-493
-92% -$14.3K ﹤0.01% 2911
2024
Q4
$17.2K Hold
536
﹤0.01% 1806
2024
Q3
$16.3K Buy
+536
New +$18.5K ﹤0.01% 1635
2024
Q2
Sell
-24
Closed -$1.01K 2118
2024
Q1
$1.01K Buy
+24
New +$908 ﹤0.01% 2018
2022
Q3
Sell
-165
Closed -$7K 2269
2022
Q2
$7K Hold
165
﹤0.01% 2082
2022
Q1
$7K Sell
165
-2,820
-94% -$97.2K ﹤0.01% 2222
2021
Q4
$70K Hold
2,985
﹤0.01% 1324
2021
Q3
$85K Hold
2,985
﹤0.01% 1236
2021
Q2
$99K Buy
2,985
+420
+16% +$12.4K ﹤0.01% 1170
2021
Q1
$65K Hold
2,565
﹤0.01% 1495
2020
Q4
$72K Hold
2,565
﹤0.01% 1276
2020
Q3
$36K Hold
2,565
﹤0.01% 1384
2020
Q2
$47K Buy
2,565
+1,000
+64% +$19.5K ﹤0.01% 1240
2020
Q1
$26K Sell
1,565
-3,501
-69% -$123K ﹤0.01% 1398
2019
Q4
$225K Sell
5,066
-20
-0.4% -$802 0.01% 659
2019
Q3
$206K Buy
5,086
+400
+9% +$17.6K 0.01% 654
2019
Q2
$237K Hold
4,686
0.01% 611
2019
Q1
$260K Buy
4,686
+1,006
+27% +$54.8K 0.02% 569
2018
Q4
$175K Sell
3,680
-1,322
-26% -$81.2K 0.01% 643
2018
Q3
$343K Buy
5,002
+922
+23% +$58.9K 0.02% 475
2018
Q2
$260K Hold
4,080
0.02% 492
2018
Q1
$271K Hold
4,080
0.02% 451
2017
Q4
$263K Hold
4,080
0.02% 461
2017
Q3
$212K Sell
4,080
-550
-12% -$27.2K 0.02% 494
2017
Q2
$251K Hold
4,630
0.03% 436
2017
Q1
$308K Buy
4,630
+460
+11% +$32.7K 0.03% 382
2016
Q4
$322K Sell
4,170
-650
-13% -$46.2K 0.04% 349
2016
Q3
$324K Hold
4,820
0.04% 340
2016
Q2
$330K Hold
4,820
0.05% 323
2016
Q1
$272K Buy
+4,820
New +$255K 0.04% 361

Other funds holding HP

Geneos Wealth Management's HP Position: Q4 2025 in Review

Geneos Wealth Management sold out of Helmerich & Payne (HP) in Q4 2025, closing a stake of 500 shares — an estimated $11K sold.

Geneos Wealth Management first reported a position in HP in Q1 2016 and held it in 32 quarters. The position peaked at $343K in Q3 2018. 360 funds tracked by Wall St. Rank hold HP as of Q4 2025.

  • Geneos Wealth Management reported no remaining Helmerich & Payne position as of Q4 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 500 Helmerich & Payne shares in Q4 2025, an estimated $11K.
  • Geneos Wealth Management first reported a position in Helmerich & Payne in Q1 2016 and held it in 32 quarters.
  • Geneos Wealth Management's Helmerich & Payne position peaked at $343K in Q3 2018.
  • 360 funds tracked by Wall St. Rank held Helmerich & Payne as of Q4 2025.

Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.